{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:04:36Z","timestamp":1787601876736,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515010883"],"award-info":[{"award-number":["2021A1515010883"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.yexcr.2021.112488","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T21:55:12Z","timestamp":1611611712000},"page":"112488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["EIF3H knockdown inhibits malignant melanoma through regulating cell proliferation, apoptosis and cell cycle"],"prefix":"10.1016","volume":"402","author":[{"given":"Wenjun","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2021.112488_bib1","first-page":"215","article-title":"Malignant melanoma: prevention, early detection, and treatment in the 21st century","volume":"50","author":"Rigel","year":"2010","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2021.112488_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/DAD.0b013e31828a2ec5","article-title":"Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers","volume":"36","author":"Ossama","year":"2014","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.yexcr.2021.112488_bib3","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2021.112488_bib4","first-page":"7","article-title":"Cancer statistics","volume":"69","author":"Siegel","year":"2019","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2021.112488_bib5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-3-642-38007-5_25","article-title":"Novel approaches in melanoma prevention and therapy","volume":"159","author":"Grimaldi","year":"2014","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.yexcr.2021.112488_bib6","first-page":"660","article-title":"Malignant melanoma and central nervous system metastases. Incidence, diagnosis, treatment and survival","volume":"42","author":"Amer","year":"2015","journal-title":"Cancer-Am. Cancer Soc."},{"key":"10.1016\/j.yexcr.2021.112488_bib7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4149\/neo_2016_403","article-title":"Malignant melanoma: diagnosis, treatment and cancer stem cells","volume":"63","author":"Kozovska","year":"2016","journal-title":"Neoplasma"},{"key":"10.1016\/j.yexcr.2021.112488_bib8","doi-asserted-by":"crossref","first-page":"E5930","DOI":"10.1073\/pnas.1705206114","article-title":"BRAFV600 inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells","volume":"114","author":"Lunavat","year":"2017","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.yexcr.2021.112488_bib9","first-page":"2251","article-title":"Trametinib: a MEK inhibitor for management of metastatic melanoma","volume":"8","author":"Lugowska","year":"2015","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.yexcr.2021.112488_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biopha.2017.01.045","article-title":"A mini-review of c-Met as a potential therapeutic target in melanoma","volume":"88","author":"Doa","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexcr.2021.112488_bib11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ejso.2016.10.014","article-title":"Developments in targeted therapy in melanoma","volume":"43","author":"Amann","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.yexcr.2021.112488_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/15476286.2017.1391437","article-title":"eIF3: a factor for human health and disease","volume":"15","author":"Gomesduarte","year":"2017","journal-title":"RNA Biol."},{"key":"10.1016\/j.yexcr.2021.112488_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature14267","article-title":"eIF3 targets cell-proliferation messenger RNAs for translational activation or repression","volume":"522","author":"Lee","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2021.112488_bib14","doi-asserted-by":"crossref","first-page":"10948","DOI":"10.1093\/nar\/gkx805","article-title":"Embraced by eIF3: structural and functional insights into the roles of eIF3 across the translation cycle","volume":"45","author":"Val\u00e1\u0161ek","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2021.112488_bib15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.bbagrm.2014.10.005","article-title":"The role of eIF3 and its individual subunits in cancer","volume":"1849","author":"Hershey","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2021.112488_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.gene.2018.06.034","article-title":"The function and clinical significance of eIF3 in cancer","volume":"673","author":"Yin","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.yexcr.2021.112488_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canlet.2017.09.055","article-title":"eIF3a: a new anticancer drug target in the eIF family","volume":"412","author":"Yin","year":"2018","journal-title":"Canc. Lett."},{"key":"10.1016\/j.yexcr.2021.112488_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tice.2018.05.006","article-title":"Eukaryotic translation initiation factor EIF3H potentiates gastric carcinoma cell proliferation","volume":"53","author":"Wang","year":"2018","journal-title":"Tissue Cell"},{"key":"10.1016\/j.yexcr.2021.112488_bib19","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1080\/09168451.2018.1484271","article-title":"The proliferation of colorectal cancer cells is suppressed by silencing of EIF3H","volume":"82","author":"Yu","year":"2018","journal-title":"Biosc. Biotech. Biochem."},{"key":"10.1016\/j.yexcr.2021.112488_bib20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2021.112488_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (Anti\u2013PD-1) in melanoma","volume":"369","author":"Hamid","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2021.112488_bib22","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1200\/JCO.2004.10.125","article-title":"Prevalence of KIT expression in human tumors","volume":"22","author":"Went","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2021.112488_bib23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2021.112488_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"Improved survival with MEK inhibition in BRAF-mutated melanoma","volume":"367","author":"Flaherty","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2021.112488_bib25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ccr.2010.11.023","article-title":"Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R\/PI3K","volume":"18","author":"Villanueva","year":"2010","journal-title":"Canc. Cell"},{"key":"10.1016\/j.yexcr.2021.112488_bib26","doi-asserted-by":"crossref","first-page":"24047","DOI":"10.1074\/jbc.M800956200","article-title":"An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3","volume":"283","author":"Zhang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2021.112488_bib27","first-page":"155","article-title":"Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma","volume":"19","author":"Chai","year":"2019","journal-title":"Canc. Cell Int."},{"key":"10.1016\/j.yexcr.2021.112488_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-018-0538-8","article-title":"mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis","volume":"561","author":"Choe","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2021.112488_bib29","doi-asserted-by":"crossref","first-page":"49888","DOI":"10.18632\/oncotarget.10222","article-title":"Elevated expression of eukaryotic translation initiation factor 3H is associated with proliferation, invasion and tumorigenicity in human hepatocellular carcinoma","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2021.112488_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3892\/or.2016.4821","article-title":"Effects of TMEM9 gene on cell progression in hepatocellular carcinoma by RNA interference","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2021.112488_bib31","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0002-9440(10)65433-8","article-title":"Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer","volume":"154","author":"Nupponen","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2021.112488_bib32","first-page":"4925","article-title":"Eukaryotic translation initiation factor 3H suppression inhibits osteocarcinoma cell growth and tumorigenesis","volume":"15","author":"Hong","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.yexcr.2021.112488_bib33","first-page":"2339","article-title":"UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT\/mTOR pathway","volume":"11","author":"Ye","year":"2019","journal-title":"Canc. Manag. Res."},{"key":"10.1016\/j.yexcr.2021.112488_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13046-019-1138-7","article-title":"TRIM44 activates the AKT\/mTOR signal pathway to induce melanoma progression by stabilizing TLR4","volume":"38","author":"Wei","year":"2019","journal-title":"J. Exp. Clin. Canc. Res."},{"key":"10.1016\/j.yexcr.2021.112488_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2019.03.004","article-title":"SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT\/GSK-3\u03b2\/\u03b2-catenin pathway","volume":"59","author":"Wan","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.yexcr.2021.112488_bib36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.yexcr.2016.07.004","article-title":"NF-\u03baB-dependent transcriptional upregulation of cyclin D1 exerts cytoprotection against hypoxic injury upon EGFR activation","volume":"347","author":"Chen","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2021.112488_bib37","first-page":"3679","article-title":"MicroRNA-365 inhibits cell growth and promotes apoptosis in melanoma by targeting BCL2 and cyclin D1 (CCND1)","volume":"24","author":"Zhu","year":"2018","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res. : international medical journal of experimental and clinical research"},{"key":"10.1016\/j.yexcr.2021.112488_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41389-018-0081-3","article-title":"Oncogenic PI3K\/AKT promotes the step-wise evolution of combination BRAF\/MEK inhibitor resistance in melanoma","volume":"7","author":"Irvine","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.yexcr.2021.112488_bib39","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1080\/15548627.2015.1049800","article-title":"RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy","volume":"11","author":"Luan","year":"2015","journal-title":"Autophagy"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721000197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721000197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:35:50Z","timestamp":1757997350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482721000197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0014482721000197"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112488","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EIF3H knockdown inhibits malignant melanoma through regulating cell proliferation, apoptosis and cell cycle","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112488"}}